Medtronic co-founder Earl Bakken, who invented the world’s first wearable, battery-powered pacemaker, died on Oct. 21 in his Hawaii home, the company announced. He was 94.

A team of Chicago researchers has identified four genetic variants specific to people of African ancestry which may help explain their increased incidence of warfarin-associated bleeding events.

Managing their high blood pressure is the best way patients with diabetes can avoid hypertensive emergencies, according to research published in Clinical and Experimental Hypertension this fall.

Women with early-stage breast cancer who receive large doses of radiation once a week for five weeks will experience the same long-term side effects as women who undergo conventional radiation therapy, according to a ten-year study presented Oct. 21 at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.

A small-scale pilot study has linked omega-3 fatty acid supplementation to improved social function and reduced cognitive depression in patients with combined chronic heart failure (CHF) and major depressive disorder.

A new study published in the Journal of the American College of Cardiology provides reassurance that TAVR is a safe alternative to surgical aortic valve replacement (SAVR) in low-risk patients, as zero of the 200 people undergoing the transcatheter procedure died or experienced a disabling stroke within 30 days.

Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for patients with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

Certain antiphospholipid antibodies were detected more often after heart attacks than for age-matched controls, suggesting the markers could be used to identify patients at high risk of myocardial infarction, according to a study published Oct. 22 in the Annals of Internal Medicine.